PRESS RELEASE

Integromics Biomarker Discovery 2.0 for Tibco Spotfire

Tibco Software, together with Intergromics, has released Integromics Biomarker Discovery 2.0 for Tibco Spotfire, a solution for advanced methods of data access, normalisation, pattern detection, treatment comparison, and functional analysis for analysis of genomic expression data.

The scientific and workflow knowledge of Intergromics, combined with the adaptability and ease of use of the Tibco Spotfire Enterprise Analytics Platform, provides pharmaceutical, biotechnology, and academic research groups with a powerful genomic data analysis environment that quickly finds and categorises complex patterns. With interactive analysis and high-impact visualisation capabilities, Integromics Biomarker Discovery 2.0 rapidly reveals insights and unexpected relationships in genomics data. This allows researchers and scientists to examine the expression and annotation dimensions of their data and perform a variety of numerical analyses.

Company: 
Feature

Gemma Church finds out how astronomers are using simulations to investigate the extremities of our universe

Feature

Turning data into scientific insight is not a straightforward matter, writes Sophia Ktori

Feature

The Leibniz Supercomputing Centre (LRZ) is driving the development of new energy-efficient practices for HPC, as Robert Roe discovers

Feature

William Payne investigates the growing trend of using modular HPC, built on industry standard hardware and software, to support users across a range of both existing and emerging application areas

Feature

Robert Roe looks at developments in crash testing simulation – including larger, more intricate simulations, the use of optimisation software, and the development of new methodologies through collaboration between ISVs, commercial companies, and research organisations